Mabs – The Secret Agents Fighting MS
June 4, 2019What do the MS treatments ocrelizumab, alemetuzumab and natalizumab (Ocrevus, Lemtrada, and Tysabri) have in common?read more
MS Treatments
Ocrelizumab Reduces Upper Extremity Disability Progression Risk in PPMS
February 13, 2019Study results published show a noticeably reduced risk for progression of upper extremity (UE) disability compared with placebo in patients with primary progressive multiple sclerosis (PPMS)read more
Interferon-Beta, Glatiramer Acetate Equally Effective for Relapsing-Remitting MS
February 13, 2019Interferon-Beta, Glatiramer Acetate Equally Effective for Relapsing-Remitting MSread more
CAN BLOOD STEM CELLS REBOOT THE IMMUNE SYSTEM?
November 7, 2017There is a great deal of scientific and community interest in the role that stem cells might play in treating MS. Stem cell therapy is a treatment that uses or targets stem…read more
DO ANTI-INFLAMMATORY DRUGS DELAY DISABILITY IN SECONDARY PROGRESSIVE MS?
November 7, 2017While there has been great progress in the development of effective treatments for relapsing remitting MS over the last 15 years, there has not been the same advances in treatments…read more
RELAPSING MS TREATMENT CLADRIBINE ON THE COMEBACK
November 7, 2017Cladribine, an oral treatment for relapsing remitting MS, previously approved in Australia, but subsequently withdrawn, is making a comeback.read more
FIRST TREATMENT FOR PRIMARY PROGRESSIVE MS APPROVED IN AUSTRALIA
September 11, 2017MS Research Australia has been reporting on every step that Ocrevus a new MS medication, has taken on its journey to become the first ever approved treatment for progressive MS…read more
BEGINNINGS OF A UNIQUE NEW APPROACH FOR TREATING MS
July 10, 2017Our blood brain barrier is an amazing part of the body that keeps the brain and spinal cord highly protected, allowing through only those cells and nutrients that are needed…read more
COMMON ACNE MEDICATION MAY HELP DELAY A DIAGNOSIS OF MS
June 19, 2017Canadian researchers have published their results of a clinical trial testing whether an antibiotic commonly used in the treatment of acne can help prevent a diagnosis of MS in people…read more
FDA approves Ocrelizumab for relapsing-remitting and primary progressive MS
April 3, 2017The American Food and Drug Administration (FDA) has approved OCREVUS™ (ocrelizumab) for the treatment of both relapsing and primary progressive forms of multiple sclerosis.read more
Doctors back unconventional treatment for multiple sclerosis
March 27, 2017On the ABC News 7-30 Report recently, the MS Research Australia Chief Executive Officer, Dr Matthew Miles, featured in a report discussing the approach to the management of MS founded…read more
The importance of early treatment in MS
March 27, 2017Experts in Europe recently held a debate and discussion at the European Parliament with an audience of critical stakeholders about the importance of early diagnoses and access to treatment in…read more
Is your treatment working? Perhaps your genes can tell
March 6, 2017In the past decade, several treatments for MS have become available. Many of these target cells in the immune system. However, determining which treatment would be best for everyone with…read more
Big-data analysis shows not all MS treatments are equal
March 6, 2017A large international study led by Dr Tomas Kalincik of The University of Melbourne together with the global MSBase Consortium has shown that the treatments alemtuzumab (Lemtrada) and natalizumab (Tysabri)…read more
New study shows benefits of current treatments for people with advanced MS
December 10, 2016Contrary to the notion that current treatments only benefit early stage MS, new research has shown that taking treatments that modify the immune system can improve the disease course even…read more
New plant-derived substance shows promise as a new therapy option for MS
December 10, 2016New research has just been released which has shown that a new plant derived compound can delay and reduce MS symptoms in an animal model of MS. Natural products continue…read more
High dose biotin shows promise for the treatment of progressive MS
October 31, 2016While treatment options are currently available for relapsing MS, there are no treatments for the progressive forms of the disease. This is a significant unmet need in the MS community…read more
Modern treatment era has substantially improved clinical outcomes for people with MS
October 31, 2016Over the last 15 years the treatment landscape has substantially improved for people with relapsing remitting MS, and in Australia 11 disease modifying therapy options are currently available for people…read more
Media reports about autologous haematopoietic stem cell transplant
October 31, 2016There are many stories in the media about autologous haematopoietic stem cell transplant, also known as bone marrow transplant, AHSCT or HSCT, as a treatment for MS.read more
Zinbryta receives TGA approval in Australia for use in relapsing MS
October 31, 2016The Australian Therapeutic Goods Administration (TGA) has approved the registration of disease modifying multiple sclerosis (MS) medication, Zinbryta (daclizumab) on the Australian Register of Therapeutic Goods.read more